Xencor, Inc. - ROE
XNCR
Price:
$12.64
Market Cap:
$937.15M
Xencor Inc., a biopharmaceutical firm headquartered in Monrovia, California, and established in 1997, operates as a clinical-stage entity. Its central mission involves the discovery and sophisticated engineering of monoclonal antibody and cytokine therapeutics, primarily aimed at treating patients afflicted with cancer and autoimmune disorders. The company is associated with several notable therapies currently in use, such as Sotrovimab, which targets the SARS-CoV-2 virus; Ultomiris, prescribed for paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome; and Monjuvi, indicated for individuals with relapsed or refractory diffuse large B-cell lymphoma. Xencor maintains a rob...[Read more]
Industry
Biotechnology
IPO Date
2013-12-03
Stock Exchange
NASDAQ
Ticker
XNCR
PE Ratio
[-5.52]
ROE
[-28.77%]
Current Ratio
[6.57]
Dividend Yield
[0%]
Enterprise Value
[1.10B]
Dividend History
The ROE as of June 2026 (TTM) for Xencor, Inc. (XNCR) is -28.77%
According to Xencor, Inc.’s latest financial reports and current stock price. The company's current ROE is -28.77%. This represents a change of 259.89% compared to the average of -8.00% of the last 4 quarters.
Xencor, Inc. (XNCR) Historical ROE (quarterly & annually)
How has XNCR ROE performed in the past?
The mean historical ROE of Xencor, Inc. over the last ten years is -9.59%. The current -28.77% ROE has changed 199.99% with respect to the historical average. Over the past ten years (40 quarters), XNCR's ROE was at its highest in in the June 2016 quarter at 22.61%. The ROE was at its lowest in in the March 2026 quarter at -25.00%.
Average
-9.59%
Median
-12.80%
Minimum
-34.33%
Maximum
11.27%
Xencor, Inc. (XNCR) ROE by Quarter and Year
Discovering the peaks and valleys of Xencor, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 162.44%
Maximum Annual ROE = 11.27%
Minimum Annual Increase = -367.34%
Minimum Annual ROE = -34.33%
| Year | ROE | Change |
|---|---|---|
| 2025 | -14.46% | -57.87% |
| 2024 | -34.33% | 72.45% |
| 2023 | -19.91% | 162.44% |
| 2022 | -7.59% | -167.33% |
| 2021 | 11.27% | -193.01% |
| 2020 | -12.11% | -367.34% |
| 2019 | 4.53% | -133.57% |
| 2018 | -13.50% | -22.19% |
| 2017 | -17.35% | -330.52% |
| 2016 | 7.52% | -169.48% |
Xencor, Inc. (XNCR) Average ROE
How has XNCR ROE performed in the past?
The current ROE of Xencor, Inc. (XNCR) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-22.90%
5-year avg
-13.00%
10-year avg
-9.59%
Xencor, Inc. (XNCR) ROE vs. Peers
How is XNCR’s ROE compared to its peers?
Xencor, Inc.’s ROE is greater than Nurix Therapeutics, Inc. (-64.21%), greater than Oculis Holding AG (-57.09%), greater than Kodiak Sciences Inc. (-253.85%), less than Phathom Pharmaceuticals, Inc. (39.24%), less than UroGen Pharma Ltd. (121.52%), less than AnaptysBio, Inc. (442.91%), greater than Nektar Therapeutics (-87.00%), greater than Tango Therapeutics, Inc. (-41.54%), greater than Mind Medicine (MindMed) Inc. (-102.48%), greater than BridgeBio Oncology Therapeutics Inc. (-61.49%),
| Company | ROE | Market cap |
|---|---|---|
| -64.21% | $1.52B | |
| -57.09% | $641.44M | |
| -253.85% | $1.91B | |
| 39.24% | $867.74M | |
| 121.52% | $1.64B | |
| 442.91% | $2.48B | |
| -87.00% | $1.19B | |
| -41.54% | $3.48B | |
| -102.48% | $1.56B | |
| -61.49% | $605.61M |
Build a custom stock screener for Xencor, Inc. (XNCR) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Xencor, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Xencor, Inc. (XNCR) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Xencor, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Xencor, Inc.'s ROE?
How is the ROE calculated for Xencor, Inc. (XNCR)?
What is the highest ROE for Xencor, Inc. (XNCR)?
What is the 3-year average ROE for Xencor, Inc. (XNCR)?
What is the 5-year average ROE for Xencor, Inc. (XNCR)?
How does the current ROE for Xencor, Inc. (XNCR) compare to its historical average?